On-Demand Webinars
-
C3 Summit
2/16/2022
TransPerfect Life Sciences' C3 Summit brings to you virtual sessions on how the paper to digital migration is evolving, the use and application of eCOA migration technology, and setting up successful eCOA solutions.
-
The Cutting Edge Of Pharma: AI And RWD
1/19/2024
Taken from a spotlight session at the CNS Summit, gain insights from thought leaders from Norstella and Citeline regarding artificial intelligence and real-world data.
-
Using Technology To Reduce Monitoring Costs And Increase Quality
2/18/2025
Join industry experts as they discuss how the true value of DDC lies not just in the cost of the technology itself but in the operational efficiencies it unlocks.
-
Exploring The Role Of Wearable Biosensors Within The DCT Ecosystem
3/28/2022
In this pre-recorded webinar, experts from the industry share real-world insights and practical guidance on how to achieve success in decentralized clinical trials.
-
Measuring Treatment Tolerability In Oncology: Expert Panel Discussion
2/19/2026
Learn how to synthesize individual symptomatic data into a comprehensive narrative of tolerability, ultimately enhancing the clinical value and regulatory positioning of your oncology assets.
-
Reducing Macroeconomic Pressures On Clinical Trial Supply: Session 2
4/28/2023
Join IRT industry veteran and drug supply expert Stefan Dürr for a discussion about how to reduce the impact of both traditional and emerging macroeconomic pressures on clinical trial supply.
-
Clinical Trial Management System
4/22/2022
Watch to learn the reasons why research sites, site networks, health systems, academic medical centers, and cancer centers use a CTMS to centralize information related to protocols, subjects, staff, financials and billing, and much more.
-
Unlocking The Promise of Digital Health Technologies In Clinical Trials
3/23/2026
Discover the scientific, regulatory, and operational hurdles slowing digital health in clinical trials — and how design, guidance, and validation improvements are moving adoption ahead.
-
Accelerating Rare Disease Drug Development With Wearable DHTs
12/8/2023
Watch as experts from ActiGraph, Bellerophon Therapeutics, and IQVIA come together to explore the obstacles and potential breakthroughs in rare disease research.
-
Advancing ALS Research With DHTs: Where Are We Now?
4/9/2024
Rakesh Pilkar, Ph.D., and Marcin Straczkiewicz, Ph.D., unveil their latest endeavors in devising innovative metrics to quantify gait and upper limb movement for monitoring ALS progression.